Hope everyone had a chance to join the call. Rohan answered a lot of questions and provided renewed confidence.
Essentially things have been quiet as they have been focused on the pipeline, with some announcements to come within weeks. RP11 is on track for Phase 1 this year.
they have deprioritised accessing US capital markets for now - as biotech equities have taken a beating
PYC, page-26
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.010(8.33%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.0¢ | 12.0¢ | $249.2K | 1.966M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 254743 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 242275 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |